Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark stock market indices rallied in early trade on Monday, even as crude oil prices stayed elevated above $100, showing that investors are looking beyond immediate risks.

The BSE Sensex was trading at 77,334.39, up 670.18 points or 0.87%, while the NSE Nifty 50 gained 199.80 points or 0.84% to 24,097.75.

The gains come after recent losses, suggesting a recovery driven by bargain buying and selective optimism.

SECTORAL PERFORMANCE ON NIFTY

All major sectoral indices were trading in the green.

  • Nifty Metal led gains, up 2.11%
  • Nifty Healthcare rose 2.57%
  • Nifty Realty gained 1.93%
  • Nifty IT climbed 1.64%
  • Nifty Auto was up 1.03%
  • Nifty FMCG added 0.99%

Banking indices were relatively muted, with Nifty Bank up just 0.18% and Nifty Financial Services rising 0.40%.

GAINERS AND LOSERS ON SENSEX

Buying was visible across most frontline stocks.

Among the top gainers were:
Sun Pharma, M&M, Ultratech Cement, TCS, LT, Asian Paints and SBI.

IT stocks such as Infosys and Tech Mahindra also traded higher, recovering after recent weakness.

On the losing side, only a handful of stocks were under pressure, including Axis Bank, Bajaj Finance and BEL.

WHY ARE MARKETS RISING?

The current upmove is largely a technical rebound after a sharp correction in the last few sessions. Lower valuations in large-cap stocks have attracted buying interest.

At the same time, broader markets are showing strength, with midcap and smallcap indices rising over 1%, indicating wider participation.

However, the macro risks remain intact.

“With the geopolitical situation showing no improvement and crude inching higher the implications for India’s macros and markets continue to be negative in the near-term,” said Dr VK Vijayakumar, Chief Investment Strategist at Geojit Investments Limited.

GLOBAL CUES SUPPORT SENTIMENT

Global markets, especially in the US, have been supported by strong momentum in technology stocks linked to artificial intelligence.

This has had a spillover effect on Asian markets and India.

“Even though geopolitics and energy crisis are dominating the news a major factor impacting stock markets continues to be the AI trade. The US market, driven by AI trade, is at record highs,” Vijayakumar said.

He added that global capital flows are currently shifting towards AI-driven markets.

“AI leaders like South Korea and Taiwan are attracting huge FPI flows at the cost of emerging markets like India,” he noted.

The rally was broad-based, with most sectoral indices trading in the green.

IT stocks rose over 1.5%, metals gained more than 2%, and sectors like pharma, realty and auto also saw buying interest.

Banking stocks were relatively muted but still positive, indicating stability in the market.

OIL REMAINS THE KEY OVERHANG

Despite the rally, crude oil prices continue to be a major concern.

Brent crude remained above $106–$107 per barrel, while WTI hovered around $95, reflecting ongoing geopolitical tensions and supply concerns.

This remains a key risk for India’s economy.

“Markets will continue to remain volatile responding to news,” Vijayakumar said, highlighting the uncertainty linked to global developments.

WHAT NEXT FOR MARKETS

The near-term outlook remains uncertain, with multiple global and domestic factors at play.

Any reversal in global AI-driven flows could change the direction of markets.

“Any reversal of AI trade will also alter the direction of portfolio flows,” Vijayakumar said.

For now, the market is balancing optimism from domestic growth with caution from global risks.

“In the current state of total uncertainty, investors can wait and watch the geopolitical developments and take decisions as clarity emerges,” he added.

Latest

Is NPS Swasthya enough for medical emergencies? Here’s the reality

With rising healthcare costs, many are turning to NPS Swasthya as a safety net. But is it enough when a real emergency strikes? The answer may not be as reassur

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

Decoding the Sun Pharma $11.75 billion deal: Why the pharma stock jumped 7% today?

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, reflecting strong investor interest

Paytm shares tumble 6% today: Is this dip a buying chance for investors?

Paytm shares fell 6% today. Is this panic-driven weakness, or a smart chance for investors to buy into the fintech stock at lower levels now?

Topics

Is NPS Swasthya enough for medical emergencies? Here’s the reality

With rising healthcare costs, many are turning to NPS Swasthya as a safety net. But is it enough when a real emergency strikes? The answer may not be as reassur

Cursor AI Agent wipes out startup database in 9 seconds, founder shares 30-hour chaos timeline

A startup founder said Cursor AI Agent erased the company database in nine seconds. The account traced 30 hours of disruption after the incident.

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Watch out Apple and Samsung, OpenAI is making AI smartphone with agentic capabilities

OpenAI is reportedly working with MediaTek and Qualcomm on smartphone processors, aiming to build an AI-first device powered by agent-led experiences.

ICSE, ISC board results to be out this week? Here’s what CISCE official has to say

The Council for the Indian School Certificate Examinations (CISCE) will declare the much-awaited ICSE Class 10 and ISC Class 12 Results 2026 shortly. Officials

Sam Altman says Codex is causing major FOMO so he changing his sleep schedule

Sam Altman says GPT-5.5 in Codex is so good he’s cutting sleep. He has said due to AI he has switched to polyphasic sleep — a schedule involving multiple sh

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

30 students suspended at Hansraj College over fest chaos, DUSU calls it undemocratic

Hansraj College has placed around 30 students, including four elected union office-bearers, under interim suspension over alleged misconduct tied to its annual
spot_img

Related Articles

Popular Categories

spot_imgspot_img